Top Markets
Coin of the day
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Clasificación en acciones #30835
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Precio por acción
$0.089
Última sincronización: 2026-08-17
Capitalización bursátil
$15.36M
Cambio (1 día)
50.59%
Cambio (1 año)
72.65%
País
US
Comercio Inhibitor Therapeutics, Inc. (INTI)

Categoría

Historial de desdoblamientos de acciones de Inhibitor Therapeutics, Inc. (INTI)
La acción Inhibitor Therapeutics, Inc. (símbolo: INTI) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 19, 2026.
Una acción INTI comprada antes de Aug 19, 2026 equivaldría hoy a 0 acciones INTI.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE